Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Singapore

Prudential Assurance Co Singapore (Pte) Ltd v Tan Shou Yi Peter and another [2021] SGHC 109

In Prudential Assurance Co Singapore (Pte) Ltd v Tan Shou Yi Peter and another, the High Court of the Republic of Singapore addressed issues of Contract — Breach, Contract — Illegality and public policy.

Case Details

  • Citation: [2021] SGHC 109
  • Case Title: Prudential Assurance Co Singapore (Pte) Ltd v Tan Shou Yi Peter and another
  • Court: High Court of the Republic of Singapore (General Division)
  • Coram: Chua Lee Ming J
  • Decision Date: 05 May 2021
  • Case Number: Suit No 772 of 2016
  • Judgment Reserved: 5 May 2021
  • Plaintiff/Applicant: Prudential Assurance Company Singapore (Pte) Ltd (“PACS”)
  • Defendants/Respondents: (1) Tan Shou Yi Peter (“Peter”); (2) PTO Management and Consultancy Pte Ltd (“PTOMC”)
  • Legal Areas: Contract – Breach; Contract – Illegality and public policy (restraint of trade); Contract – Remedies (damages); Equity – Fiduciary relationships (duties; when arising; remedies including account); Tort – Confidence; Tort – Conspiracy
  • Statutes/Regulatory Instruments Referenced (as provided): Preparatory Steps and Act
  • Counsel for Plaintiff: K. Muralidharan Pillai SC, Paul Tan, Luo Qinghui, Jared Kok, Andrea Tan, Tao Tao and Joey Ng (Rajah & Tann Singapore LLP)
  • Counsel for First Defendant: Thio Shen Yi SC, Niklas Wong, Nanthini Vijayakumar and Nguyen Vu Lan (TSMP Law Corporation)
  • Counsel for Second Defendant: Nicholas Poon (Breakpoint LLC)
  • Judgment Length: 72 pages; 34,216 words

Summary

Prudential Assurance Co Singapore (Pte) Ltd v Tan Shou Yi Peter and another [2021] SGHC 109 arose from a large-scale agency “exodus” in mid-2016 involving agents who had sold PACS insurance products through a structured, tiered distribution model. PACS alleged that Peter, the leader of the largest agent group within its distribution network, solicited 244 agents to leave PACS and join a competitor, Aviva Limited (“Aviva”), and/or Aviva’s financial advisory subsidiary, Aviva Financial Advisors Pte Ltd (“AFA”). PACS sought substantial damages (including loss of profits) and, alternatively, equitable relief in the form of an account of profits.

The High Court (Chua Lee Ming J) addressed multiple overlapping causes of action, including breach of contract, breach of fiduciary duties, and related equitable and tortious claims (confidence and conspiracy). The dispute also engaged the regulatory context governing insurance distribution in Singapore, particularly the Monetary Authority of Singapore (“MAS”) framework and industry guidelines that shaped the structure and supervision of agents. The judgment is notable for its careful treatment of when fiduciary duties arise in an agency relationship, how contractual and equitable remedies interact, and how illegality/public policy considerations may affect enforceability of restraints.

What Were the Facts of This Case?

PACS sold life insurance products primarily through a tied agency model, supported by additional distribution through banks. The tied agency network was not a simple one-to-one relationship between PACS and individual agents. Instead, it operated through a tiered structure designed to comply with MAS and industry guidelines on efficient and transparent distribution of life insurance. Agents were independent contractors rather than employees. Their role was to canvass and recruit, but they did not have authority to commit PACS to enter into insurance contracts; PACS retained the final decision on whether to accept proposals and conclude insurance agreements.

Within this structure, agents could also be promoted to supervisory or leadership roles. Tier 1 agents generally sold policies and recruited new agents. Tier 2 agency leaders supervised Tier 1 agents and earned both commissions and “overrides” (overriding benefits) linked to the sales performance of agents under their supervision. Tier 3 agency leaders (including Group Agency Leaders (“GALs”) and Group Agency Managers (“GAMs”)) supervised Tier 2 leaders and, depending on their type, also had additional override entitlements. The tiered system was designed to align with MAS Notice 306 and the “Span of Control” guidelines issued through LIA undertakings, which limited the number of persons within an agency unit and capped the number of tiers where overrides were paid.

The immediate trigger for litigation was a coordinated termination of agency agreements. Between 15 and 17 June 2016, 195 PACS agents gave notice of termination en masse. By the end of June 2016, a further 31 agents had done the same. Additional agents terminated in July 2016 and again between August 2016 and 27 February 2017. In total, 244 agents terminated their PACS agency arrangements. Of these, 241 had belonged to the Peter Tan Organisation (“PTO”), which was run by Peter and was described as PACS’s biggest and most successful agent group.

Peter himself terminated his own agency agreement with PACS on 8 July 2016. PACS responded by summarily terminating Peter’s agency agreement for breach. PACS then commenced proceedings alleging that Peter breached his agency agreement and/or fiduciary duties by soliciting the 244 agents to leave PACS to join Aviva and/or AFA. PACS claimed damages for breach, with loss of profits ranging from approximately $2.4 million to $2.5 billion. Alternatively, PACS sought equitable compensation (including an account of profits) against Peter. PACS also claimed against the second defendant, PTOMC, for dishonest assistance in relation to Peter’s alleged breach of fiduciary duties, and alternatively for an account of benefits received by PTOMC.

Peter counterclaimed against PACS. His counterclaims included damages for wrongful termination of his agency agreement, inducing certain agents to breach confidential obligations owed to him, breach of confidential obligations, and conspiracy to injure Peter by unlawful means. The counterclaims were tied to alleged confidential information obtained by certain agents during meetings with Peter between April and early June 2016. PACS maintained that Peter carried out the solicitation during those meetings.

First, the court had to determine whether Peter’s conduct amounted to breach of contract. This required close attention to the terms of Peter’s agency agreement(s) with PACS, including any provisions governing solicitation, recruitment, confidentiality, and post-termination conduct. The case also raised the question whether any contractual restrictions could be characterised as restraints of trade and, if so, whether they were enforceable or affected by illegality/public policy.

Second, the court had to consider whether Peter owed fiduciary duties to PACS in the relevant circumstances, and if so, whether he breached those duties by soliciting agents to join a competitor. This issue was not simply whether a fiduciary relationship existed in the abstract; it required analysis of the particular role Peter played within PACS’s distribution network, the degree of influence and control he had, and the nature of the information and opportunities he allegedly used or diverted.

Third, the court had to address remedies and causation. PACS sought damages (including loss of profits) and, alternatively, equitable compensation and/or an account of profits. The court therefore had to decide not only liability but also the appropriate measure of relief, including whether equitable remedies were available and how they should be quantified. In parallel, the court had to deal with Peter’s counterclaims grounded in confidence and conspiracy, which depended on whether confidential information was misused and whether unlawful means were involved.

How Did the Court Analyse the Issues?

The court began by situating the dispute within the regulatory and commercial realities of Singapore’s insurance distribution market. The MAS and LIA framework did not merely provide background; it shaped the structure of agency relationships and the supervision of agents. The judgment explained that MAS Notice 306 required direct life insurers to cap tier structures to a maximum of three tiers where overriding benefits were payable, and to ensure training and competency through a Training and Competency Plan. LIA undertakings (including those dealing with “span of control”) limited the number of representatives within an agency unit and imposed competency and coaching requirements. These constraints influenced how PACS organised its agency leaders and how overrides were calculated.

Against that backdrop, the court analysed the nature of the agency relationship. Although agents were independent contractors, the tiered structure created functional dependencies: Tier 2 and Tier 3 leaders supervised other agents and earned overrides based on the sales performance of those under them. The court treated this as relevant to whether fiduciary duties could arise. In particular, the analysis focused on whether Peter’s position involved a duty of loyalty and whether he had access to information or influence that could create a conflict between his personal interests and PACS’s interests. The judgment’s approach reflects a broader principle in fiduciary law: fiduciary duties do not arise solely because parties are in a commercial relationship; they arise where the relationship involves trust, confidence, and a duty to act in the interests of another in a way that makes the fiduciary character appropriate.

On the contractual front, the court examined whether Peter’s solicitation of agents breached the agency agreement. This required identifying the relevant contractual obligations and then mapping the evidence of Peter’s conduct onto those obligations. The factual narrative—mass termination notices by agents associated with PTO, followed by Peter’s own termination—was central to the court’s assessment of causation and inference. The court also had to consider whether the contractual provisions could be construed as restraints of trade. Where contractual restrictions operate to prevent a party from competing or soliciting customers/agents, the court typically assesses enforceability by reference to public policy and whether the restraint is reasonable in scope and duration and protects legitimate interests.

Equity and remedies formed another major strand of analysis. PACS pursued equitable compensation and an account of profits as alternatives to damages. The court therefore considered the circumstances in which an account of profits is available, and how it differs from damages. An account of profits is concerned with stripping the defendant of gains made through wrongdoing, whereas damages aim to compensate the claimant for loss. The judgment also had to address whether PTOMC’s involvement could amount to dishonest assistance, which requires proof that the defendant assisted a breach of fiduciary duty with the requisite knowledge or dishonesty. The court’s treatment of PTOMC’s liability would have depended on the factual findings about what PTOMC did, what Peter communicated, and whether PTOMC’s conduct met the threshold for dishonest assistance.

Finally, the court addressed Peter’s counterclaims. The claims for inducement of breach and breach of confidential obligations required the court to determine whether confidential information existed, whether it was communicated to agents, and whether it was used in a way that breached obligations owed to Peter. The conspiracy to injure claim required proof of an agreement or combination to use unlawful means to cause harm. These issues required careful evidential analysis, particularly because the same meetings in April to early June 2016 were alleged by PACS to be the solicitation events and by Peter to be the source of confidential information.

What Was the Outcome?

The High Court’s decision resolved the competing claims of PACS and Peter arising from the mass agent terminations and the alleged solicitation and diversion of agents to Aviva/AFA. The court’s orders reflected its findings on liability under contract and equity, as well as its conclusions on whether fiduciary duties were breached and whether equitable remedies were warranted. The judgment also addressed PTOMC’s alleged dishonest assistance and Peter’s counterclaims relating to confidence and conspiracy.

In practical terms, the outcome determined whether PACS could recover damages or equitable compensation (including an account of profits) and whether Peter’s counterclaims succeeded in undermining PACS’s basis for summary termination. The decision therefore had significant commercial implications for insurance distribution disputes, particularly where agency leaders move networks of agents to competitors.

Why Does This Case Matter?

This case matters because it illustrates how fiduciary principles can be applied in modern insurance distribution structures where agents are independent contractors but occupy leadership roles within a tiered system. The judgment demonstrates that fiduciary duties may arise from the substance of the relationship and the nature of the role, not merely from employment status. For practitioners, this is a reminder that agency leadership positions can carry heightened duties of loyalty and avoidance of conflicts, especially where the leader has influence over recruitment and the flow of opportunities between parties.

Second, the case is instructive on the interaction between contractual claims and equitable remedies. Where a claimant seeks both damages and equitable relief, the court’s analysis of appropriate remedies and the evidential burden for equitable compensation/account of profits can guide litigation strategy. The decision also highlights the importance of causation and quantification, particularly in disputes involving large numbers of agents and claims for loss of profits.

Third, the judgment’s engagement with the regulatory context (MAS and LIA guidelines) underscores that insurance distribution disputes cannot be understood in isolation from the compliance architecture that governs agent structures, tiers, and overrides. This regulatory backdrop can affect how courts interpret the commercial realities of agency relationships and the reasonableness of any restraint-related arguments.

Legislation Referenced

  • Preparatory Steps and Act (as provided in the metadata)

Cases Cited

  • [2021] SGHC 109 (as provided in the metadata)

Source Documents

This article analyses [2021] SGHC 109 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.

Written by Sushant Shukla

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.